Access Campaign
MSF warns governments are failing to test, treat and prevent TB in children
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
MSF South Asia Health and Humanity Summit: Partnering to build better responses during emergencies
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
